Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Adolescent Psychiatry
  4. Volume 15, Issue 1
  5. Article
Volume 15, Issue 1
  • ISSN: 2210-6766
  • E-ISSN: 2210-6774

Abstract

Adolescence is a unique developmental period marked by biophysiological changes and psychosocial exploration. Risk-taking behaviors, including experimentation with psychoactive substances, are common during this period. Emergency room (ER) visits for adverse events related to adolescent substance use have increased over the last two decades. Without a continuum of care from the ER, significant opportunities to intervene are missed. The narrative review article aims to provide an overview of substance use during Adolescence in the United States, highlight related ER visits, and discuss extending care beyond the ER. A literature review was conducted to reveal historical and recent studies related to adolescent substance use trends, morbidity, and mortality patterns, as well as the much-needed continuum of care after the ER. Our approach prioritized capturing diverse perspectives and significant studies relevant to these themes, aiming for a thorough discussion without strict adherence to systematic review methodologies. The selection of studies involved a comprehensive search across multiple databases, including PubMed, Google Scholar, and relevant academic journals. Search terms were tailored to capture studies addressing adolescent substance abuse, ER visitation, and aftercare. Studies were screened based on title, abstract, and full-text review, with a focus on relevance and significance to the review's objectives. The strategy for this narrative review facilitated a detailed exploration of the selected themes while also allowing for flexibility in study selection and interpretation. National studies indicate an overall decline in the proportions of adolescents using substances compared to pre-COVID-19 levels. However, morbidity and mortality patterns have not mirrored this decline. Various factors, including gender, location, and specific mental health disorders, are associated with adolescent substance use presentations. Acute care providers in emergency settings, employing protocols like SBIRT, can significantly impact outcomes by facilitating appropriate screening and referral to aftercare treatment programs. Identification of barriers to care, such as stigma and social determinants of health, is important in formulating tailored interventions. While acute care provides an opportunity to intervene and initiate treatment, a continuum of care is essential to reduce morbidity and mortality patterns among adolescents with substance use.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aps/10.2174/0122106766304121240718112939
2024-07-22
2025-06-21

  • From This Site

    /content/journals/aps/10.2174/0122106766304121240718112939
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AcevedoA. HarveyN. KamanuM. TendulkarS. FlearyS. Barriers, facilitators, and disparities in retention for adolescents in treatment for substance use disorders: a qualitative study with treatment providers.Subst. Abuse Treat. Prev. Policy20201514210.1186/s13011‑020‑00284‑432552836
     [Google Scholar]
  2. Adolescent health.Available from:https://www.who.int/health-topics/adolescent-health#tab=tab_1(accessed on 15-7-2024)2023
  3. AfusehE. PikeC.A. OrucheU.M. Individualized approach to primary prevention of substance use disorder: age-related risks.Subst. Abuse Treat. Prev. Policy20201515810.1186/s13011‑020‑00300‑732795372
     [Google Scholar]
  4. Alcohol and Drug Foundation.Available from: https://adf.org.au/drug-facts/new-psychoactive-substances/(accessed on 15-7-2024)2013
  5. AssiS. MarshallD. BersaniF.S. CorazzaO. Uses, effects and toxicity of synthetic cannabinoids from the perspective of people with lived experiences.J. Psychoactive Drugs202052323724710.1080/02791072.2020.172374832027228
     [Google Scholar]
  6. BartonE.D. RamosJ. ColwellC. BensonJ. BailyJ. DunnW. Intranasal administration of naloxone by paramedics.Prehosp. Emerg. Care200261545810.1080/1090312029093879711789651
     [Google Scholar]
  7. BasuliD. RoyS. Elevated anion gap metabolic acidosis with high osmolar gap and increased serum acetone level: A case report.Cureus2022147e2708510.7759/cureus.2708536000112
     [Google Scholar]
  8. BeckerlegW. HudginsJ. Substance use-related emergency department visits and resource utilization.West. J. Emerg. Med.202223216617310.5811/westjem.2022.1.5383435302449
     [Google Scholar]
  9. BiagioniS. BaldiniF. BaroniM. CerraiS. MelisF. PotenteR. ScaleseM. MolinaroS. Adolescents’ psychoactive substance use during the first COVID-19 lockdown: a cross sectional study in Italy.Child Youth Care Forum202352364165910.1007/s10566‑022‑09701‑035909702
     [Google Scholar]
  10. BirtelM.D. WoodL. KempaN.J. Stigma and social support in substance abuse: Implications for mental health and well-being.Psychiatry Res.20172521810.1016/j.psychres.2017.01.09728237758
     [Google Scholar]
  11. Blest-HopleyG. ColizziM. GiampietroV. BhattacharyyaS. Is the adolescent brain at greater vulnerability to the effects of cannabis? A narrative review of the evidence.Front. Psychiatry20201185910.3389/fpsyt.2020.0085933005157
     [Google Scholar]
  12. BlythS. H. CowieK. JurinskyJ. HennessyE. A. A qualitative examination of social identity and stigma among adolescents recovering from alcohol or drug use.Addict Behav Rep.20231810050510.1016/j.abrep.2023.100505
     [Google Scholar]
  13. BorodovskyJ.T. LevyS. FishmanM. MarschL.A. Buprenorphine treatment for adolescents and young adults with opioid use disorders: A narrative review.J. Addict. Med.201812317018310.1097/ADM.000000000000038829432333
     [Google Scholar]
  14. BukkeV.N. ArchanaM. VillaniR. ServiddioG. CassanoT. Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health.Pharmaceuticals (Basel)2021141096510.3390/ph1410096534681189
     [Google Scholar]
  15. Centers for Disease Control and Prevention.2021Available from:https://www.cdc.gov/healthyyouth/data/yrbs/index.htm(accessed on 2-7-2024)
  16. CostaG. & GołembiowskaK. Neurotoxicity of MDMA: Main effects and mechanisms.In Experimental Neurology.2022
     [Google Scholar]
  17. CoultonS. AlamM. F. BonifaceS. DelucaP. DonoghueK. GilvarryE. KanerE. LynchE. MaconochieI. McArdleP. McGovernR. 2019Opportunistic screening for alcohol use problems in adolescents attending emergency departments: an evaluation of screening tools.J Public Health (Oxf).411e53e6010.1093/pubmed/fdy049
     [Google Scholar]
  18. CraigS.G. AmesM.E. BondiB.C. PeplerD.J. Canadian adolescents’ mental health and substance use during the COVID-19 pandemic: Associations with COVID-19 stressors.Canadian Journal of Behavioural Science / Revue canadienne des sciences du comportement2023551465510.1037/cbs0000305
     [Google Scholar]
  19. CurrieJ.M. SchnellM.K. SchwandtH. ZhangJ. Trends in drug overdose mortality in Ohio during the first 7 months of the COVID-19 pandemic.JAMA Netw. Open202144e21711210.1001/jamanetworkopen.2021.711233852004
     [Google Scholar]
  20. de AndradeD. ElphinstonR.A. QuinnC. AllanJ. HidesL. The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review.Drug Alcohol Depend.201920122723510.1016/j.drugalcdep.2019.03.03131254749
     [Google Scholar]
  21. DemariaF. VicariS. Adolescent distress: is there a vaccine? Social and cultural considerations during the COVID-19 pandemic.Int. J. Environ. Res. Public Health2023203181910.3390/ijerph2003181936767187
     [Google Scholar]
  22. DirA.L. GilmoreA.K. MorelandA.D. DavidsonT.M. BorkmanA.L. RheingoldA.A. DanielsonC.K. What’s the harm? Alcohol and marijuana use and perceived risks of unprotected sex among adolescents and young adults.Addict. Behav20187628128410.1016/j.addbeh.2017.08.035
     [Google Scholar]
  23. DodgeK.A. SkinnerA.T. GodwinJ. BaiY. LansfordJ.E. CopelandW.E. Benjamin GoodmanW. McMahonR.J. GoulterN. BornsteinM.H. PettitG.S. BatesJ.E. Impact of the COVID-19 pandemic on substance use among adults without children, parents, and adolescents.Addict. Behav. Rep.20211410038810.1016/j.abrep.2021.10038834938846
     [Google Scholar]
  24. E.M.C.D.D.A. Drugs in Focus.14th edEMCDDALn.d.
     [Google Scholar]
  25. EstradaC.A.M. LomboyM.F.T.C. GregorioE.R.Jr AmaliaE. LeynesC.R. QuizonR.R. KobayashiJ. Religious education can contribute to adolescent mental health in school settings.Int. J. Ment. Health Syst.20191312810.1186/s13033‑019‑0286‑731057663
     [Google Scholar]
  26. DubeS.R. MillerJ.W. BrownD.W. GilesW.H. FelittiV.J. DongM. AndaR.F. Adverse childhood experiences and the association with ever using alcohol and initiating alcohol use during adolescence.J. Adolesc. Health2006384444.e1444.e1010.1016/j.jadohealth.2005.06.00616549308
     [Google Scholar]
  27. EvenK.M. ArmsbyC.C. BatemanS.T. Poisonings requiring admission to the pediatric intensive care unit: A 5-year review.Clin. Toxicol. (Phila.)201452551952410.3109/15563650.2014.90960124738737
     [Google Scholar]
  28. FahimiJ. AurrecoecheaA. AndersonE. HerringA. AlterH. 2015Substance abuse and mental health visits among adolescents presenting to US emergency departments.Pediatr Emerg Care.31533133810.1097/PEC.0000000000000421
     [Google Scholar]
  29. FontanellaC. A. SteelesmithD. L. BrockG. BridgeJ. A. CampoJ. V. FristadM. A. 2021Association of cannabis use with self-harm and mortality risk among youths with mood disorders.JAMA Pediatr.175437738410.1001/jamapediatrics.2020.5494
     [Google Scholar]
  30. FriedmanJ. GodvinM. ShoverC.L. GoneJ.P. HansenH. SchrigerD.L. Trends in drug overdose deaths among US adolescents, January 2010 to June 2021.JAMA2022327141398140010.1001/jama.2022.284735412573
     [Google Scholar]
  31. GeorgeP. WahlM. Cannabis toxicity in children and adolescents.Pediatr. Ann.2023525e181e18610.3928/19382359‑20230307‑0437159059
     [Google Scholar]
  32. GodleyS.H. GarnerB.R. PassettiL.L. FunkR.R. DennisM.L. GodleyM.D. Adolescent outpatient treatment and continuing care: Main findings from a randomized clinical trial.Drug Alcohol Depend.20101101-2445410.1016/j.drugalcdep.2010.02.00320219293
     [Google Scholar]
  33. GomesT. TadrousM. MamdaniM.M. PatersonJ.M. JuurlinkD.N. The burden of opioid-related mortality in the United states.JAMA Netw. Open201812e18021710.1001/jamanetworkopen.2018.021730646062
     [Google Scholar]
  34. GrigsbyT.J. ForsterM. UngerJ.B. SussmanS. Predictors of alcohol‐related negative consequences in adolescents: A systematic review of the literature and implications for future research.J. Adolesc.2016481183510.1016/j.adolescence.2016.01.00626871952
     [Google Scholar]
  35. GuirguisA. New psychoactive substances: a public health issue.Int. J. Pharm. Pract.201725532332510.1111/ijpp.1231328895252
     [Google Scholar]
  36. HadlandS.E. XuanZ. SardaV. BlanchetteJ. SwahnM.H. HeerenT.C. VoasR.B. NaimiT.S. 2017Alcohol policies and alcohol-related motor vehicle crash fatalities among young people in the US.10.1542/peds.2016‑3037
     [Google Scholar]
  37. HallW. LeungJ. LynskeyM. The effects of cannabis use on the development of adolescents and young adults.Annual Review of Developmental Psychology20202146148310.1146/annurev‑devpsych‑040320‑084904
     [Google Scholar]
  38. HammondC.J. MayesL.C. PotenzaM.N. Neurobiology of adolescent substance use and addictive behaviors: treatment implications. In: AM:STARs: Substance Use and Abuse Among Adolescents.201410.1542/9781581108903‑neurobiology
     [Google Scholar]
  39. HannaR.C. PerezJ.M. GhoseS. Cannabis and development of dual diagnoses: A literature review.Am. J. Drug Alcohol Abuse201743444245510.1080/00952990.2016.121327327612527
     [Google Scholar]
  40. HarrisS.K. KnightJ.R.Jr Van HookS. SherrittL. TraciL.B. KuligJ.W. ChristinaA.N. SaitzR. Adolescent substance use screening in primary care: Validity of computer self-administered versus clinician-administered screening.Subst. Abus.201637119720310.1080/08897077.2015.101461525774878
     [Google Scholar]
  41. HochA.M. SchoenbergerS.F. BoyleT.P. HadlandS.E. GaiM.J. BagleyS.M. Attitudes and training related to substance use in pediatric emergency departments.Addict. Sci. Clin. Pract.20221715910.1186/s13722‑022‑00339‑w36274146
     [Google Scholar]
  42. HootsB.E. LiJ. HertzM.F. EsserM.B. RicoA. ZavalaE.Y. JonesC.M. Alcohol and other substance use before and during the COVID-19 pandemic among high school students — Youth risk behavior survey, United States, 2021.MMWR Suppl.2023721849210.15585/mmwr.su7201a1037104552
     [Google Scholar]
  43. HudginsJ.D. PorterJ.J. MonuteauxM.C. BourgeoisF.T. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study.PLoS Med.20191611e100292210.1371/journal.pmed.100292231689290
     [Google Scholar]
  44. JerniganD. NoelJ. LandonJ. ThorntonN. & LobsteinT. Alcohol marketing and youth alcohol consumption: a systematic review of longitudinal studies published since 2008.In Addiction.2017
     [Google Scholar]
  45. KroonE. KuhnsL. CousijnJ. The short-term and long-term effects of cannabis on cognition: recent advances in the field.Curr. Opin. Psychol.202138495510.1016/j.copsyc.2020.07.00532823178
     [Google Scholar]
  46. KuleszaM. Substance use related stigma: What we know and the way forward. Journal of Addictive Behaviors Therapy and Rehabilitation,20133520120810.4172/2324‑9005.1000106
     [Google Scholar]
  47. LeungK.S. Ben AbdallahA. CopelandJ. CottlerL.B. Modifiable risk factors of ecstasy use: Risk perception, current dependence, perceived control, and depression.Addict. Behav.201035320120810.1016/j.addbeh.2009.10.00319880258
     [Google Scholar]
  48. LevyS.J.L. WilliamsJ.F. RyanS.A. GonzalezP.K. PatrickS.W. QuigleyJ. SiqueiraL. SmithV.C. WalkerL.R. Substance use screening, brief intervention, and referral to treatment.Pediatrics20161381e20161211e110.1542/peds.2016‑121127325634
     [Google Scholar]
  49. LevyS. BrognaM. MinegishiM. SubramaniamG. McCormackJ. KlineM. MenzinE. Allende-RichterS. FullerA. LewisM. CollinsJ. HubbardZ. MitchellS.G. WeissR. WeitzmanE. Assessment of screening tools to identify substance use disorders among adolescents.JAMA Netw. Open202365e231442210.1001/jamanetworkopen.2023.1442237213103
     [Google Scholar]
  50. LevyS. WeissR. SherrittL. ZiemnikR. SpaldingA. Van HookS. ShrierL.A. An electronic screen for triaging adolescent substance use by risk levels.JAMA Pediatr.2014168982282810.1001/jamapediatrics.2014.77425070067
     [Google Scholar]
  51. LiskolaJ. HaravuoriH. LindbergN. NiemeläS. KarlssonL. KiviruusuO. MarttunenM. AUDIT and AUDIT-C as screening instruments for alcohol problem use in adolescents.Drug Alcohol Depend.201818826627310.1016/j.drugalcdep.2018.04.01529803033
     [Google Scholar]
  52. LivneO. ShmulewitzD. WalshC. HasinD.S. Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP.Addiction2022117123099310910.1111/add.1598735978453
     [Google Scholar]
  53. LordS. MarschL. Emerging trends and innovations in the identification and management of drug use among adolescents and young adults.Adolesc. Med. State Art Rev.2011223649669, xiv22423469
     [Google Scholar]
  54. MadrasB. K. AhmadN. J. WenJ. SharfsteinJ. S. Improving access to evidence-based medical treatment for opioid use disorder: Strategies to address key barriers within the treatment system.NAM Perspect.202010.31478/202004b
     [Google Scholar]
  55. MarschL.A. MooreS.K. BorodovskyJ.T. SolhkhahR. BadgerG.J. SeminoS. JarrettK. CondonK.D. RossettieK. VincentP. HajizadehN. DucatE. A randomized controlled trial of buprenorphine taper duration among opioid‐dependent adolescents and young adults.Addiction201611181406141510.1111/add.1336326918564
     [Google Scholar]
  56. MasonbrinkA.R. MiddlebrooksL. GoodingH.C. AbellaM. HallM. BurgerR.K. GoyalM.K. Substance use disorder visits among adolescents at children’s hospitals during COVID-19.J. Adolesc. Health202270467367610.1016/j.jadohealth.2021.12.02435177345
     [Google Scholar]
  57. McCabeS.E. VelizP.T. BoydC.J. SchepisT.S. McCabeV.V. SchulenbergJ.E. A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife.Drug Alcohol Depend.201919437738510.1016/j.drugalcdep.2018.10.02730481692
     [Google Scholar]
  58. McCartyD. BraudeL. LymanD.R. DoughertyR.H. DanielsA.S. GhoseS.S. Substance abuse intensive outpatient programs: assessing the evidence.Psychiatr Serv.2014656718726
     [Google Scholar]
  59. MiechR.A. JohnstonL.D. PatrickM.E. O’MalleyP.M. BachmanJ.G. SchulenbergJ.E. Monitoring the Future national survey results on drug use, 1975-2022: Secondary school students.Institute for Social Research, University of Michigan2023
     [Google Scholar]
  60. MitchellS.G. GryczynskiJ. O’GradyK.E. SchwartzR.P. SBIRT for adolescent drug and alcohol use: Current status and future directions.J. Subst. Abuse Treat.201344546347210.1016/j.jsat.2012.11.00523352110
     [Google Scholar]
  61. MitchellS.G. KellyS.M. GryczynskiJ. MyersC.P. O’GradyK.E. KirkA.S. SchwartzR.P. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination.Subst. Abus.201435437638010.1080/08897077.2014.93699225036144
     [Google Scholar]
  62. MoormanL.K. COVID-19 pandemic-related transition to telehealth in child and adolescent mental health.In Family Relations.2021
     [Google Scholar]
  63. Synthetic Cathinones ("Bath Salts").2020Available from:https://nida.nih.gov/publications/drugfacts/synthetic-cathinones-bath-salts/(accessed on 2-7-2024)
  64. Reported drug use among adolescents continued to hold below pre-pandemic levels in 2023.2023Available from:https://nida.nih.gov/news-events/news-releases/2023/12/reported-drug-use-among-adolescents-continued-to-hold-below-pre-pandemic-levels-in-2023(accessed on 2-7-2024)
  65. NorthS. Expanding telehealth in adolescent care: Moving beyond the COVID-19 pandemic.Pediatrics.2023151S1e2022057267J
     [Google Scholar]
  66. OjeahereM.I. KiburiS.K. AgboP. KumarR. & JagugaF. Telehealth interventions for substance use disorders in low- and- middle income countries: A scoping review (V. Lichtner, Ed.; Vol. 2;1(11):e0000125).2022
     [Google Scholar]
  67. OladunjoyeA.F. LiE. AneniK. Onigu-OtiteE. Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States.PLoS One20231810e029292210.1371/journal.pone.029292237847698
     [Google Scholar]
  68. Onigu-OtiteE. KurtzweilM. TucciV. MoukaddamN. Substance use in adolescents presenting to the emergency department.Adolesc. Psychiatry (Hilversum)20209214215810.2174/2210676608666181015114220
     [Google Scholar]
  69. OrsoliniL. CorkeryJ.M. ChiappiniS. GuirguisA. VentoA. De BerardisD. PapantiD. SchifanoF. “New/Designer Benzodiazepines”: an analysis of the literature and psychonauts’ trip reports.Curr. Neuropharmacol.202018980983710.2174/1570159X1866620011012133331933443
     [Google Scholar]
  70. PathanH. WilliamsJ. Basic opioid pharmacology: an update.Br. J. Pain201261111610.1177/204946371243849326516461
     [Google Scholar]
  71. PelhamW.E.III TapertS.F. GonzalezM.R. McCabeC.J. LisdahlK.M. AlzuetaE. BakerF.C. BreslinF.J. DickA.S. DowlingG.J. GuillaumeM. HoffmanE.A. MarshallA.T. McCandlissB.D. ShethC.S. SowellE.R. ThompsonW.K. Van RinsveldA.M. WadeN.E. BrownS.A. Early adolescent substance use before and during the COVID-19 pandemic: A longitudinal survey in the ABCD study cohort.J. Adolesc. Health202169339039710.1016/j.jadohealth.2021.06.01534452728
     [Google Scholar]
  72. PierceR.P. StevermerJ.J. Disparities in use of telehealth at the onset of the COVID-19 public health emergency.Journal of Telemedicine and Telecare20202911357633X2096389
     [Google Scholar]
  73. PigeaudL. de VeldL. van der LelyN. Elevated creatinine kinase levels amongst Dutch adolescents with acute alcohol intoxication.Eur. J. Pediatr.202318231371137510.1007/s00431‑023‑04820‑936662269
     [Google Scholar]
  74. PintoriN. LoiB. MereuM. Synthetic cannabinoids: the hidden side of Spice drugs.Behavioural Pharmacology201728640919
     [Google Scholar]
  75. Rivas-VazquezR. A. & DelgadoL. Clinical and toxic effects of MDMA (. Ecstasy").Prof. Psychol. Res. Pr.2002334422
     [Google Scholar]
  76. RoehlerD.R. SmithH.IV RadhakrishnanL. HollandK.M. GatesA.L. Vivolo-KantorA.M. HootsB.E. Cannabis-involved emergency department visits among persons aged <25 years before and during the COVID-19 pandemic — United States, 2019–2022.MMWR Morb. Mortal. Wkly. Rep.2023722875876510.15585/mmwr.mm7228a137440436
     [Google Scholar]
  77. RomanoE. FellJ. LiK. Simons-MortonB.G. VacaF.E. Alcohol-related deaths among young passengers: An analysis of national alcohol-related fatal crashes.J. Safety Res.20217937638210.1016/j.jsr.2021.10.00434848017
     [Google Scholar]
  78. RousisN. BadeR. Romero-SánchezI. MuellerJ.F. ThomaidisN.S. ThomasK.V. Gracia-LorE. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.Environ. Int.202317810807510.1016/j.envint.2023.10807537399770
     [Google Scholar]
  79. RyanS.A. KokotailoP. CamengaD.R. PatrickS.W. PlumbJ. QuigleyJ. Walker-HardingL. Alcohol use by youth.Pediatrics20191441e2019135710.1542/peds.2019‑1357
     [Google Scholar]
  80. SAMSHA.Available from: https://www.samhsa.gov/(accessed on 15-7-2024)2023
  81. SantillanesG. AxeenS. LamC.N. MenchineM. National trends in mental health-related emergency department visits by children and adults, 2009–2015.Am. J. Emerg. Med.202038122536254410.1016/j.ajem.2019.12.03531902702
     [Google Scholar]
  82. SchwinnT.M. SchinkeS.P. TrentD.N. Substance use among late adolescent urban youths: Mental health and gender influences.Addict. Behav.2010351303410.1016/j.addbeh.2009.08.00519716660
     [Google Scholar]
  83. SellersC.M. Diaz-Valdes IriarteA. Wyman BattalenA. O’BrienK.H.M. Alcohol and marijuana use as daily predictors of suicide ideation and attempts among adolescents prior to psychiatric hospitalization.Psychiatry Res.201927367267710.1016/j.psychres.2019.02.00631207851
     [Google Scholar]
  84. SettipaniC.A. HawkeL.D. VirdoG. YorkeE. MehraK. HendersonJ. Social determinants of health among youth seeking substance use and mental health treatment.J Can Acad Child Adolesc Psychiatry.2018274213221
     [Google Scholar]
  85. ShafiA. BerryA.J. SumnallH. WoodD.M. TracyD.K. New psychoactive substances: a review and updates.Ther. Adv. Psychopharmacol.20201010.1177/204512532096719733414905
     [Google Scholar]
  86. ShaverJ. The state of telehealth before and after the COVID-19 pandemic.Prim Care.2022494517530
     [Google Scholar]
  87. SimioniN. RollandB. CottencinO. Interventions for increasing alcohol treatment utilization among patients with alcohol use disorders from emergency departments: A systematic review.J. Subst. Abuse Treat.201558v61510.1016/j.jsat.2015.06.00326206477
     [Google Scholar]
  88. SinghG. DausG. AllenderM. RameyC. MartinE. PerryC. ReyesA. VedamuthuI. Social determinants of health in the United States: Addressing major health inequality trends for the nation, 1935-2016.International Journal of MCH and AIDS20176213916410.21106/ijma.236
     [Google Scholar]
  89. SpiritoA. Sindelar-ManningH. ColbyS.M. BarnettN.P. LewanderW. RohsenowD.J. Individual and family motivational interventions for alcohol-positive adolescents treated in an emergency department.Arch Pediatr Adolesc Med.2011165326927410.1001/archpediatrics.2010.296
     [Google Scholar]
  90. StatonC.A. VissociJ.R.N. WojcikR. HirshonJ.M. MvungiM. MmbagaB.T. SwahnM. Perceived barriers by health care providers for screening and management of excessive alcohol use in an emergency department of a low-income country.Alcohol201871657310.1016/j.alcohol.2018.01.00330055405
     [Google Scholar]
  91. StringfieldS.J. TorregrossaM.M. Disentangling the lasting effects of adolescent cannabinoid exposure.Prog. Neuropsychopharmacol. Biol. Psychiatry202110411006710.1016/j.pnpbp.2020.11006732791165
     [Google Scholar]
  92. SuntharalingamS. JohnsonD. SureshS. ThierraultF.L. De SanteS. PerinpanayagamP. SalamatmaneshM. PajerK. Rates of dual diagnosis in child and adolescent psychiatric inpatients: A scoping review.J. Addict. Med.202216110110910.1097/ADM.000000000000081833534276
     [Google Scholar]
  93. Tanner-SmithE.E. WilsonS.J. LipseyM.W. The comparative effectiveness of outpatient treatment for adolescent substance abuse: A meta-analysis.J. Subst. Abuse Treat.201344214515810.1016/j.jsat.2012.05.00622763198
     [Google Scholar]
  94. TanzL. J. DinwiddieA. T. MattsonC. L. O’DonnellJ. DavisN. L. Drug overdose deaths among persons aged 10-19 years - United States, July 2019-December 2021.MMWR Morb Mortal Wkly Rep.201971501576158210.15585/mmwr.mm7150a2
     [Google Scholar]
  95. TaoR. ShokryI.M. CallananJ.J. Environment influencing serotonin syndrome induced by ecstasy abuse.Ann. Forensic Res. Anal.201741103929732414
     [Google Scholar]
  96. TomášJ. LenkaŠ. 2023Prevalence of dual diagnoses among children and adolescents with mental health conditions.Children10229310.3390/children10020293
     [Google Scholar]
  97. VitaleSG. Substance use among emergency room patients: Is self-report preferable to biochemical markers?Addict Behav.20063191661166910.1016/j.addbeh.2005.12.011
     [Google Scholar]
  98. SMART Update.2016Available from: https://www.unodc.org/documents/scientific/Global-SMART-Update-2016-vol-16.pdf(accessed on 15-7-2024)
  99. VolkowN. D. BlancoC. 2020Medications for opioid use disorders: clinical and pharmacological considerations.J Clin Invest.13011013
     [Google Scholar]
  100. WalkerM. CarpinoM. LightfootD. RossiE. TangM. MannR. SaarelaO. CusimanoM.D. The effect of recreational cannabis legalization and commercialization on substance use, mental health, and injury: a systematic review.Public Health2023221879610.1016/j.puhe.2023.06.01237429043
     [Google Scholar]
  101. WarrenB.J. Evidence-Based Assessment and Management of Substance Abuse and Addiction Spectrum. A Practical Guide to Child and Adolescent Mental Health Screening, Evidence-Based Assessment.In Intervention, and Health Promotion.2021
     [Google Scholar]
  102. WilliamsK. LangE.S. PanchalA.R. GasperJ.J. TaillacP. GoudaJ. LyngJ.W. GoodloeJ.M. HedgesM. Evidence-based guidelines for EMS administration of naloxone.Prehosp. Emerg. Care201923674976310.1080/10903127.2019.159795530924736
     [Google Scholar]
  103. WinstockA.R. BarrattM.J. 2013Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample.Drug Alcohol Depend.1311-210611110.1016/j.drugalcdep.2012.12.011
     [Google Scholar]
  104. WintersK. Tanner-SmithE. BresaniE. MeyersK. 2014Current advances in the treatment of adolescent drug use.Adolesc Health Med Ther.519921010.2147/AHMT.S48053
     [Google Scholar]
  105. YoungbloodB. LiK. GehlertD.R. MedinaJ.C. SchwartzN. A novel maintenance therapeutic for Opioid Use Disorder.J. Pharmacol. Exp. Ther.2021378213314510.1124/jpet.120.00021434011529
     [Google Scholar]
  106. ZagorskiC.M. HoseyR.A. MoraffC. FergusonA. FiggattM. AronowitzS. StahlN.E. HillL.G. McElligottZ. DasguptaN. Reducing the harms of xylazine: clinical approaches, research deficits, and public health context.Harm Reduct. J.202320114110.1186/s12954‑023‑00879‑737777769
     [Google Scholar]
  107. ZhuJ.W. GonsalvesC.L. IssenmanR.M. KamA.J. Diagnosis and acute management of adolescent cannabinoid hyperemesis syndrome: A systematic review.J Adolesc Health.202168224625410.1016/j.jadohealth.2020.07.035
     [Google Scholar]
/content/journals/aps/10.2174/0122106766304121240718112939
Loading
Adolescent Substance Use, and Related Emergency Room Visits, and Continuum of Care
APS 15, 98 (2025); https://doi.org/10.2174/0122106766304121240718112939
/content/journals/aps/10.2174/0122106766304121240718112939
/content/journals/aps/10.2174/0122106766304121240718112939
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Adolescence; aftercare programs; emergency department; psychoactive substances; SBIRT; substance use

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test